# 1. Financial Performance ## A. Key Figures * **Revenue (Q4 FY26):** **₹112 Cr** Standalone (+34% QoQ) * **Gross Profit (Q4 FY26):** **₹26 Cr** Standalone (+70% QoQ; 23.4% Margin) · **₹34 Cr** Consolidated (30.5% Margin) * **EBITDA (Q4 FY26):** **₹15 Cr** Standalone (+98% QoQ; 13.4% Margin) · **₹16 Cr** Consolidated (+124% QoQ; 14.2% Margin) * **PAT (Q4 FY26):** **₹12 Cr** Standalone (+182% QoQ) · **₹1 Cr** Consolidated (vs. ₹5 Cr loss in Q3) * **Cash PAT:** **₹10 Cr** Consolidated (+170% QoQ) ## B. Sequential Revenue Recovery * **Operational Rebound:** Performance reflects a transition into a stronger operating phase, characterized by robust sequential top-line growth and strengthening business momentum. * **Demand Drivers:** Recovery is underpinned by enhanced customer engagement and a healthier product mix, though year-on-year comparisons remain challenged with revenues nearly **halving** against the prior year's period. * **Forward Outlook:** Management expects the combined mint and clove business to exceed the **INR 500 Cr** revenue mark established in FY25, following vertical expansion in Krystal. ## C. Margin Expansion Trends * **Normalization of Profitability:** Margins are migrating toward historical norms as the environment stabilizes, supported by better price realization and higher volumes. * **Input Cost Efficiency:** Gross margin expansion was significantly aided by a reduction in material costs, which moderated to **69%** of revenue during the quarter. ## D. Cash Flow & Capital Expenditure * **Depreciation Headwinds:** While cash profitability saw a triple-digit sequential surge, overall consolidated PAT was tempered by increased depreciation charges following the capitalization of the Dahej facility. * **Capex Completion:** The Dahej project is nearing finality, with **INR 260 Cr** already capitalized out of a total planned outlay of **INR 270 Cr**. --- # 2. Manufacturing & Capacity ## A. Key Figures * **Capex Investment:** **₹260 Cr – ₹270 Cr** Dahej greenfield facility * **Asset Turnover Target:** **3x – 3.5x** Expected at Dahej * **Peak Revenue Potential:** **₹800 Cr** Dahej unit * **Capacity Utilization:** **60%–65%** Current period (vs. **~80%** YoY) ## B. Dahej Facility Commencement * **Operational Milestone:** Commercial production of Gemcool 5 and Safranal commenced in late February 2026, marking the official start of the Dahej greenfield site. * **Ramp-up Timeline:** Full operations began in April 2026, with management deferring specific utilization guidance until **H2 FY 2027** to allow for stabilization. * **Qualification Progress:** The facility is currently undergoing rigorous customer and agency audits, with the qualification cycle slated for completion within the **next two quarters**. ## C. Capacity & Operational Trends * **Utilization Headwinds:** Total company utilization saw a significant year-on-year decline, primarily attributed to a slowdown in the mint segment. * **Strategic Pivot:** Management is prioritizing a recovery in utilization rates alongside a shift toward scaling high-value products and disciplined execution. ## D. Compliance & Sustainability * **Global Benchmarking:** The Silvassa plant achieved an **EcoVadis Platinum** sustainability rating, positioning the company in the top tier of global sustainability performers. * **Quality Assurance:** The new facility has successfully cleared initial global quality and compliance audits, a critical step for its commercial integration. --- # 3. Product & Segment Performance ## A. Key Figures * Revenue Growth: ~45-46% decline YoY in Q4 FY26 * **Product Portfolio:** **40+** Mint-vertical products · **70** Standalone SKUs (Gem Aromatics) ## B. Mint & Specialty Chemicals Strategy * **Vertical Integration:** Management is pivoting toward an integrated mint solution model; **Anisole** production is slated for a balanced **50-50 split** between captive use and external merchant sales. * **Cooling Agent Positioning:** Positioned as a major domestic alternative to Chinese supply (which holds **50%** global share); products act as "boosters" to enhance menthol efficacy in international and local formulations. * **Operational Flexibility:** Standalone operations utilize **fungible hardware**, allowing seamless switching between natural and synthetic production across a broad SKU base. ## C. Non-Mint Diversification * **Portfolio Evolution:** Strategic shift toward non-mint categories is yielding results, with **clove and its derivatives** cited as the primary drivers of a healthier product mix. * **Traction:** Diversification efforts are showing "encouraging progress," helping to mitigate over-reliance on traditional mint cycles. ## D. Geographic Performance & Export Headwinds * **Export Volatility:** Significant top-line contraction driven primarily by a sharp reduction in --- # 4. Strategic Initiatives ## A. Forward Integration & Product Qualification * **Vertical Integration:** Gem Aromatics is executing a forward integration strategy within its mint vertical, leveraging menthol to manufacture cooling agents for global oral care and confectionery leaders. * **Validation Milestone:** Phenol-based products have successfully cleared the qualification process, securing sample approvals from global distributors and traders awaiting commercial finalization. * **Operational Readiness:** Management confirmed technical stability and successful customer qualification regarding product quality, signaling readiness for imminent capacity scaling. * **Risk Mitigation:** Strategic focus has shifted toward internal controls and securing global approvals to insulate the business from external market volatility. ## B. CDMO & Portfolio Evolution * **Service Expansion:** Plans are underway to pivot the Dahej facility’s multipurpose capacity toward CRO, CMO, and CDMO services following plant qualification. * **Agile Manufacturing:** The company is evaluating equipment requirements to enable a volume shift between synthetic and natural offerings based on market demand. * **Growth Positioning:** Recent strategic investments and enhanced technical capabilities have positioned the firm for its next phase of long-term value creation. --- # 5. Demand & Pricing Trends ## A. Key Figures * **Consolidated Revenue:** **₹110 Cr** Current Quarter (+39.24% QoQ) ## B. Volume and Realization * **Sequential Recovery:** Robust top-line expansion driven by stronger customer engagement, increased volumes, and improved price realization following a weaker Q4. * **Momentum Shift:** Business activity is strengthening as orders return, reversing the previous quarter's decline which was primarily triggered by volume contraction. ## C. US Tariff Impacts * **Export Volatility:** Previous performance was hampered by significant volume dips in mint exports due to U.S. tariff uncertainties and delayed restocking. * **Strategic Arbitrage:** Entry into the cooling agent market leverages India’s **tariff-exempt** status for U.S. exports, providing a competitive edge over Chinese manufacturers facing trade barriers. ## D. Global Engagement & Market Equilibrium * **Normalization of Operations:** Business environment has stabilized as prior **GST headwinds** have subsided, allowing demand to return to historical norms. * **Supply Chain Positioning:** Growth is underpinned by global diversification trends and a shift in customer preference toward reliable, compliant manufacturing partners. --- # 6. Risks & Chemical Macro ## A. Raw Material & Supply Chain Volatility * **Strategic Production Deferral:** Management has intentionally delayed the continuous production of phenol-based derivatives despite the plant being production-ready since **March**; the move aims to mitigate risks from volatile spot pricing and supplier force majeures. * **Input Cost Headwinds:** Geopolitical instability has led to elevated prices and supply constraints for petrochemical feedstocks (specifically phenol), impacting near-term production timelines. * **Margin Resilience:** Despite high input costs, management indicates that current gross margins for new production lines could still align with industry standards once stabilized. ## B. Global Macroeconomic & Geopolitical Outlook * **Guidance Risk:** While confident in achieving **FY 2028** targets based on customer interest, management declined to provide specific **FY 2027** standalone guidance due to ongoing global conflicts and macro uncertainty. * **Export Dynamics:** The historical **30%** share of U.S. exports is expected to withstand Q4 volatility, as management views recent disruptions as seasonal rather than structural. * **Demand Sentiment:** Despite high inflation in the Western Hemisphere, management remains positive regarding demand for the standalone business and the long-term fundamentals of the specialty chemicals sector. ## C. Operational Mitigation * **Portfolio Diversification:** The company is counteracting macro volatility by scaling the **Dahej facility** and expanding its specialty product portfolio to reduce reliance on sensitive segments. * **Execution Strategy:** Focus remains on monitoring industry developments to align execution with long-term growth, despite a potential **six-month** window of hindered growth due to delayed product approvals and pricing issues. --- # 7. Guidance & Outlook ## A. Key Figures * **Consolidated Turnover Guidance (FY26):** **₹1,100 Cr** * **Revenue Guidance (Gem Aromatics):** **₹1,050 Cr – ₹1,100 Cr** * **Aspirational EBITDA Margin (FY28):** **16% – 18%** ## B. Fiscal 2026 & 2027 Targets * **Near-Term Revenue Outlook:** Management maintains a robust top-line target for the upcoming fiscal, though projections for the following year are deferred pending stabilization of global geopolitical uncertainties. * **FY27 Recovery Drivers:** Performance is expected to rebound toward historical levels, catalyzed by **tariff removals**, the introduction of a **value-added portfolio**, and **new production capacity** coming online. * **Guidance Timeline:** Specific financial visibility for FY27 is expected within **one to two quarters** as macroeconomic clarity improves. ## C. Long-term Margin & Vertical Strategy * **Profitability Trajectory:** Long-term margin aspirations are anchored by anticipated operating leverage as capacity utilization scales across the business. * **Vertical-Specific Caution:** Margin guidance for the Anisole vertical remains withheld until raw material costs stabilize and full-scale production is achieved. ## D. Production & Operational Ramp-up * **Asset Utilization:** Strategic priority is centered on ramping up the **Dahej facility** and scaling high-value specialty products to drive margin expansion through operational efficiencies. * **Phenol Vertical Timeline:** Production and ramp-up for phenol segments are slated for **Q1 and Q2** of the next year, aligning with an expected market equilibrium.